Related Experiment Video
Updated: Jan 24, 2026

Single Cell Fate Mapping in Zebrafish
Published on: October 5, 2011
Interferon regulatory factor 2 binding protein 2b regulates neutrophil versus macrophage fate during zebrafish
Luxiang Wang1, Shuo Gao1, Haihong Wang1
1CNRS-LIA Hematology and Cancer, Sino-French Research Center for Life Sciences and Genomics, State Key Laboratory of Medical Genomics, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
Aproper choice of neutrophil-macrophage progenitor cell fate is essential for the generation of adequate myeloid subpopulations during embryonic development and in adulthood. The network governing neutrophil-macrophage progenitor cell fate has several key determinants, such as myeloid master regulators CCAAT enhancer binding protein alpha (C/EBPα) and spleen focus forming virus proviral integration oncogene (PU.1). Nevertheless, more regulators remain to be identified and characterized. To ensure balanced commitment of neutrophil-macrophage progenitors toward each lineage, the interplay among these determinants is not only synergistic, but also antagonistic. Depletion of interferon regulatory factor 2 binding protein 2b (Irf2bp2b), a well-known negative transcription regulator, results in a bias in neutrophil-macrophage progenitor cell fate in favor of macrophages at the expense of neutrophils during the stage of definitive myelopoiesis in zebrafish embryos. Mechanistic studies indicate that Irf2bp2b acts as a downstream target of C/EBPα, repressing PU.1 expression, and that SUMOylation confers the repressive function of Irf2bp2b. Thus, Irf2bp2b is a novel determinant in the choice of fate of neutrophil-macrophage progenitor cells.
Insights
Interferon regulatory factor 2 binding protein 2b (Irf2bp2b) is crucial for balanced neutrophil and macrophage development. Its depletion biases progenitor cell fate toward macrophages, highlighting its role in myeloid lineage determination.
Area of Science:
- Developmental Biology
- Hematopoiesis
- Cell Fate Determination
Background:
- Neutrophil and macrophage production is vital for immune function.
- Key regulators like C/EBPα and PU.1 govern myeloid progenitor cell fate.
- Additional regulators are needed to understand lineage commitment.
Purpose of the Study:
- To identify novel regulators of neutrophil-macrophage progenitor cell fate.
- To characterize the role of interferon regulatory factor 2 binding protein 2b (Irf2bp2b) in myeloid development.
Main Methods:
- Investigated the function of Irf2bp2b in zebrafish embryonic myelopoiesis.
- Performed mechanistic studies to elucidate Irf2bp2b's regulatory pathway.
- Assessed the impact of Irf2bp2b depletion on progenitor cell fate.
Main Results:
- Depletion of Irf2bp2b caused a bias towards macrophages, reducing neutrophil generation.
- Irf2bp2b acts downstream of C/EBPα and represses PU.1 expression.
- SUMOylation is essential for Irf2bp2b's transcriptional repressive function.
Conclusions:
- Irf2bp2b is a novel determinant controlling neutrophil-macrophage progenitor cell fate.
- Irf2bp2b integrates upstream signals to ensure balanced myeloid lineage commitment.
- Understanding Irf2bp2b function is key to controlling myeloid cell production.
Related Concept Videos
Cooperative Binding of Transcription Regulators
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Cis-regulatory Sequences
Master Transcription Regulators

